Trial Profile
An Open-label, Randomised, Uncontrolled Trial Investigating the Pharmacokinetics of CRD007 After Single Dose Administration to Subjects With Abdominal Aortic Aneurysm (AAA)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs Pemirolast (Primary)
- Indications Abdominal aortic aneurysm
- Focus Pharmacokinetics
- Sponsors Cardoz
- 23 Apr 2014 New trial record